DXR

시간 외 거래: 9.43

Daxor Corporation (DXR)

개요 뉴스 가격 이력 토론 예측 배당 이력

Relative Volume:

Daxor Corporation Stock (DXR) Company Profile

Daxor Corporation

Healthcare (1112)

212-330-8500

Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY

최신 SEC 제출 서류

DXR's Discussions on Twitter

Compare DXR vs ISRG, BDX, ALC, MDLN, RMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
DXR Daxor Corporation	9.43	54.66M	503.40K	9.17M	-604.40K	1.8109
ISRG Intuitive Surgical Inc	468.36	165.94B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	155.52	44.30B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	80.73	38.96B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	47.93	38.69B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	228.80	33.61B	5.40B	1.49B	1.78B	10.12

Daxor Corporation Stock (DXR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2019-05-16	개시	Ascendiant Capital Markets	Buy

Daxor Corporation 주식(DXR)의 최신 뉴스

Daxor Corporation (DXR) 재무 분석

Daxor Corporation (DXR)

Daxor Corporation Stock (DXR) Company Profile

Compare DXR vs ISRG, BDX, ALC, MDLN, RMD

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Daxor Corporation 주식(DXR)의 최신 뉴스

(DXR) and the Role of Price-Sensitive Allocations - Stock Traders Daily

RSI Check: What is the long term forecast for Daxor Corporation stockEarnings Miss & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

CEO Moves: Is Daxor Corporation stock risky to hold now2026 Drop Watch & Consistent Profit Trading Strategies - baoquankhu1.vn

Insider Buying: Michael Feldschuh Acquires Additional Shares of Daxor Corp (DXR) - GuruFocus

Daxor CEO Feldschuh buys $9,070 in shares By Investing.com - Investing.com South Africa

Daxor CEO Feldschuh buys $9,070 in shares - Investing.com

DAXOR (DXR) CEO Michael Feldschuh adds 1,000 shares in open-market buy - Stock Titan

Daxor launches blood volume testing program in Ohio By Investing.com - Investing.com South Africa

Daxor Corporation Expands Customer Footprint With New BVA Program At High-Volume Ohio Cardiology Center - marketscreener.com

Daxor launches blood volume testing program in Ohio - Investing.com

Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center - GlobeNewswire

Income Plays: Is Daxor Corporation vulnerable to short sellers2026 Reactions & Smart Money Movement Tracker - baoquankhu1.vn

[N-CEN/A] DAXOR CORP SEC Filing - Stock Titan

Insider Buying: Robert Michel Acquires Shares of Daxor Corp (DXR) - GuruFocus

Michel, Daxor CFO, buys $9,900 in DXR stock - Investing.com

Michel, Daxor CFO, buys $9,900 in DXR stock By Investing.com - Investing.com India

DAXOR CORP (DXR) CFO adds 1,000 shares in open-market buy - Stock Titan

DXR PE Ratio & Valuation, Is DXR Overvalued - Intellectia AI

Setup Watch: Will Daxor Corporation stock go up in YEARNew Guidance & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Earnings Risk: What is the target price for Daxor Corporation stock2026 Biggest Moves & High Accuracy Trade Alerts - baoquankhu1.vn

Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026 - Bitget

Daxor’s Blood Volume Analysis Metric Validated as Uniquely - GlobeNewswire

Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat

Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 - Investing.com

Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 By Investing.com - Investing.com Australia

Daxor (DXR) CMO boosts stake with 5,941-share equity grant - Stock Titan

Macro Review: What is the long term forecast for Daxor Corporation stockEarnings Trend Report & Daily Price Action Insights - baoquankhu1.vn

Institution Moves: What is the earnings history of Daxor CorporationChart Signals & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Daxor Corporation to Showcase Next-Generation Portable - GlobeNewswire

Daxor to showcase next-gen portable BVA at ACC.26 session - TipRanks

Daxor (DXR) Showcases Innovative Blood Volume Analyzer at Major Cardiology Event - GuruFocus

Daxor Corporation Showcases Next-Generation Portable Blood Volume Analyzer At ACC.26 - marketscreener.com

Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions - marketscreener.com

[N-CEN] DAXOR CORP SEC Filing - Stock Titan

Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha - MarketBeat

DXR: Direct blood volume analysis drives improved outcomes and rapid revenue growth in a vast market - TradingView

Daxor (DXR) Unveils Portable Blood Volume Analyzer at Critical C - GuruFocus

Daxor Corporation Showcases New Portable Blood Volume Analyzer - marketscreener.com

Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress - TipRanks

ICU blood volume test linked to 66% fewer deaths goes portable - Stock Titan

Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 - GlobeNewswire

Market Overview: Will Murano Global Investments Plc Equity Warrant benefit from rate cuts2026 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

What analyst consensus says on Daxor Corporation stockExit Point & Fast Moving Trade Plans - Naître et grandir

Layoff Watch: Is Daxor Corporation a turnaround storyGap Up & Safe Entry Trade Reports - baoquankhu1.vn

Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200-Day Moving AverageHere's What Happened - MarketBeat

European Stocks Set for Mixed Opening Amid Geopolitical Tensions - Intellectia AI

DXR SEC FilingsDAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan

Daxor Corporation Reports 2025 Fiscal Year Results, Operating Revenue Up 45%, Net Asset Value Rises to $9.07 per Share - marketscreener.com

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - Bitget

Daxor reports 45% revenue growth, plans regulatory shift - Investing.com

Daxor Corporation CEO and President Michael Feldschuh provides corporate update in letter to shareholders - marketscreener.com

Daxor Corporation (DXR) 재무 분석

매출

순이익

현금흐름

주당 순 이익

DXR과 유사한 종목